Top compounds associated with response to NBPF9

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.19	5e-07
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.18	1e-06
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.16	6e-06
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.14	9e-06
mRNA	navitoclax:PLX-4032 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.16	1e-05
mRNA	WZ4002	CTRPv2	pan-cancer	AAC	-0.2	1e-05
mRNA	ABT-737	CTRPv2	pan-cancer	AAC	-0.16	3e-05
mRNA	UNC0638:navitoclax (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.16	4e-05
mRNA	PD 153035	CTRPv2	pan-cancer	AAC	-0.18	4e-05
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.14	7e-05

Download CSV